Innova Captab cash flow

Latest FY26

Cash from operations: ₹115cr+80.5% on FY25
Capital spending: ₹68.3cr−60.4% on FY25
Free cash flow: ₹46.9cr−₹109 cr in FY25
Cash from financing: −₹21.7cr₹91.5 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024

Adjustments to reconcile profit — non-cash items
	—	45.2	24.8	16.0
	—	−0.4	0.0	1.4
	—	16.9	0.0	21.5
	—	0.0	−3.0	−3.5
	—	0.0	0.0	1.9
	—	−1.7	0.5	−0.7
	—	2.1	6.5	0.5
	—	0.0	0.2	0.0
	—	0.0	0.1	0.0
Changes in working capital
	—	−78.8	−64.0	1.5
	—	−104	−47.7	4.5
	—	−27.3	−29.4	0.0
	—	0.0	0.0	1.6
	—	−14.3	−3.2	3.2
	—	−1.4	0.3	0.6
	—	99.8	23.7	6.3
	—	24.6	3.0	−14.0
	—	−5.3	0.3	2.7
	—	2.3	2.3	1.0
Cash from operating activities
	205	188	171	130
	—	−42.4	−85.9	44.5
	—	146	85.2	174
	—	−4.3	0.0	0.0
	—	0.0	−2.4	0.0
	—	26.3	23.7	27.7
	—	115	63.8	146
Cash from investing activities
	—	68.3	172	287
	—	7.0	0.3	0.0
	—	40.0	0.0	0.0
	—	0.0	0.0	0.1
	—	0.0	0.0	165
	—	2.8	3.9	2.5
	—	−7.3	16.7	−49.4
	—	−106	−152	−499
Cash from financing activities
	—	0.0	0.0	323
	—	33.6	106	169
	—	27.2	11.4	115
	—	0.0	0.8	0.9
	—	16.6	1.8	14.9
	—	11.4	0.0	0.0
	—	−0.1	0.0	0.0
	—	−21.7	91.5	361
	—	−12.3	3.8	8.2
	—	−12.3	3.8	8.2
	—	—	—	11.7
Reference items
	259	243	186	154
	14.8%	14.9%	15.0%	14.3%
	46.9	46.9	−109	−141
	—	35.9	−17.4	—
	₹8.19	₹8.19	−₹18.99	−₹24.64
	128.16×	—	—	—
	—	0.80×	0.50×	1.55×
	—	26.3	23.7	27.7
	—	16.6	1.8	14.9

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

INNOVACAP₹1,049.70

Innova Captab Limited

· Pharma & Health

₹ CrorePeersMOREPENLAB IOLCP FDC SENORES SANOFI ORCHPHARMA GUJTHEM RPGLIFEMcap ₹6,007 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	16.0	24.8	45.2	—
+ Impairment Loss / (Reversal)	1.4	0.0	-0.4	—
+ Finance Costs	21.5	0.0	16.9	—
+ Interest Income	-3.5	-3.0	0.0	—
+ Fair Value (Gains) / Losses	1.9	0.0	0.0	—
+ Unrealised FX (Gain) / Loss	-0.7	0.5	-1.7	—
+ Other Non-cash Items	0.5	6.5	2.1	—
+ Other — Cash Effects are Investing / Financing	0.0	0.2	0.0	—
+ Other Reconciling Items	0.0	0.1	0.0	—
Changes in Working Capital
+ Inventories	1.5	-64.0	-78.8	—
+ Trade Receivables — Current	4.5	-47.7	-104.3	—
+ Other Financial Assets — Current	0.0	-29.4	-27.3	—
+ Other Financial Assets — Non-current	1.6	0.0	0.0	—
+ Other Current Assets	3.2	-3.2	-14.3	—
+ Other Non-current Assets	0.6	0.3	-1.4	—
+ Trade Payables — Current	6.3	23.7	99.8	—
+ Other Financial Liabilities — Current	-14.0	3.0	24.6	—
+ Other Current Liabilities	2.7	0.3	-5.3	—
+ Provisions — Current	1.0	2.3	2.3	—
Cash from Operating Activities
Profit Before Tax (per I/S)	129.5	171.0	188.3	204.6
+ Total Adjustments (incl. Working Capital)	44.5	-85.9	-42.4	—
Cash from Operations (pre-tax)	174.0	85.2	145.8	—
+ Interest Received — Operating	0.0	0.0	-4.3	—
+ Interest Paid — Operating	0.0	-2.4	0.0	—
+ Income Taxes Paid	27.7	23.7	26.3	—
Cash from Operating Activities	146.3	63.8	115.2	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	287.4	172.5	68.3	—
+ Disp of Fixed Assets	0.0	0.3	7.0	—
+ Acq of Investment Property	0.0	0.0	40.0	—
+ Disp of Investment Property	0.1	0.0	0.0	—
+ Acq of Subsidiaries / Businesses (net)	164.8	0.0	0.0	—
+ Interest Received — Investing	2.5	3.9	2.8	—
+ Other Inflows / (Outflows) — Investing	-49.4	16.7	-7.3	—
Cash from Investing Activities	-499.0	-151.6	-105.8	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	323.1	0.0	0.0	—
+ Proceeds from Borrowings	168.8	105.5	33.6	—
+ Repayment of Borrowings	115.2	11.4	27.2	—
+ Payment of Lease Liabilities	0.9	0.8	0.0	—
+ Interest Paid	14.9	1.8	16.6	—
+ Dividends Paid	0.0	0.0	11.4	—
+ Other Inflows / (Outflows) — Financing	0.0	0.0	-0.1	—
Cash from Financing Activities	360.8	91.5	-21.7	—
Net Changes in Cash (pre-FX)	8.2	3.8	-12.3	—
Net Changes in Cash	8.2	3.8	-12.3	—
Closing Cash	11.7	—	—	—
Reference Items
EBITDA	154.5	186.2	242.9	259.5
EBITDA Margin %	14.28	14.97	14.90	14.83
Free Cash Flow (CFO − Capex)	-141.0	-108.7	46.9	46.9
Free Cash Flow to Equity	—	-17.4	35.9	—
Free Cash Flow per Basic Share	-24.64	-18.99	8.19	8.19
Price to Free Cash Flow	—	—	—	128.16
Cash Flow to Net Income	1.55	0.50	0.80	—
Cash Paid for Taxes	27.7	23.7	26.3	—
Cash Paid for Interest	14.9	1.8	16.6	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.